Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Osteoclast-expanded supercharged NK cells perform superior antitumour effector functions
Authors:ID Ko, Meng-Wei (Author)
ID Mei, Ao (Author)
ID Senjor, Emanuela, Institut "Jožef Stefan" (Author)
ID Perišić, Milica, Institut "Jožef Stefan" (Author)
ID Kos, Janko, Institut "Jožef Stefan" (Author)
ID Jewett, Anahid (Author), et al.
Files:URL URL - Source URL, visit https://bmjoncology.bmj.com/content/4/1/e000676
 
.pdf PDF - Presentation file, download (11,23 MB)
MD5: C8F809BFA1E4520674D9CD9F937262D2
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo IJS - Jožef Stefan Institute
Abstract:Objective. Natural killer (NK) cells are the largest innate lymphocyte subset with potent antitumour and antiviral functions. However, clinical utilisation of human NK cells is hampered due to a lack of reliable methods to augment their antitumour potential. We demonstrated technology in which human NK cells were cocultured with osteoclasts in the presence of probiotic bacteria. This approach significantly augmented the antitumour cytotoxicity and polyfunctionality of human NK cells, resulting in the generation of supercharged NK (sNK) cells. Methods and analysis. We explored the proteomic, transcriptomic and functional characterisation of sNK cells using cell imaging, flow cytometric analysis, 51-chromium release cytotoxicity assay, ELISA, ELIspot, IsoPLexis single-cell secretome analysis, proteomic analysis, RNA analysis, western blot and enzyme kinetics. Results. We found that sNK cells were less susceptible to split anergy and tumour-induced exhaustion. Proteomic analyses revealed that sNK cells significantly increased their cell motility and proliferation. Single-cell transcriptomes uncovered sNK cells undertaking a unique differentiation trajectory and turning on STAT1, JUN, BHLHE40, ELF1, MAX and MYC regulons essential for augmenting antitumour effector functions and proliferation, respectively. Both proteomic and single-cell transcriptomes revealed that an increase in Cathepsin C helped to augment the quantity and function of Granzyme B. Conclusions. These results support that this unique method produces potent NK cells for clinical utilisation and delineate the molecular mechanisms associated with this process.
Keywords:antitumour function
Publication status:Published
Publication version:Version of Record
Submitted for review:29.01.2025
Article acceptance date:28.04.2025
Publication date:10.06.2025
Publisher:BMJ Publishing Group
Year of publishing:2025
Number of pages:str. 1-20
Numbering:Vol. 4, iss. 1
Source:Združeno kraljestvo
PID:20.500.12556/DiRROS-22873 New window
UDC:616-097
ISSN on article:2752-7948
DOI:10.1136/bmjonc-2024-000676 New window
COBISS.SI-ID:241621763 New window
Copyright:© Author(s) (or their employer(s)) 2025.
Note:Nasl. z nasl. zaslona; Soavtorji iz Slovenije: Emanuela Senjor, Milica Perišić Nanut, Janko Kos; Opis vira z dne 7. 7. 2025;
Publication date in DiRROS:07.07.2025
Views:415
Downloads:256
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:BMJ oncology
Shortened title:BMJ oncol.
Publisher:BMJ
ISSN:2752-7948
COBISS.SI-ID:233823235 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0127
Name:Farmacevtska biotehnologija: znanost za zdravje

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-50102
Name:NK celična terapija glioblastoma: Modulacija cistatina F za izboljšanje učinkovitosti terapije

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-60067
Name:Izboljšanje imunoterapije raka slinavke z zaviranjem katepsinov

Funder:Other - Other funder or multiple funders
Project number:R01AI183571

Funder:Nicholas Family Foundation

Funder:Gardetto Family’s Everyday Good Foundation

Funder:Nan Gardetto Endowed Chair

Funder:AHW & Cancer Center of MCW

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.
Licensing start date:10.06.2025
Applies to:VoR

Secondary language

Language:Slovenian
Keywords:protitumorska funkcija


Back